How Bacterial Pathogens Eat Host Lipids: Implications for the Development of Fatty Acid Synthesis Therapeutics
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Bacterial type II fatty acid synthesis (FASII) is a target for the development of novel therapeutics. Bacteria incorporate extracellular fatty acids into membrane lipids, raising the question of whether pathogens use host fatty acids to bypass FASII and defeat FASII therapeutics. Some pathogens suppress FASII when exogenous fatty acids are present to bypass FASII therapeutics. FASII inhibition cannot be bypassed in many bacteria because essential fatty acids cannot be obtained from the host. FASII antibiotics may not be effective against all bacteria, but a broad spectrum of Gram-negative and -positive pathogens can be effectively treated with FASII inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotics in early life alter the murine colonic microbiome and adiposity
Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., et al. (2012) · Nature · doi:10.1038/nature11400 · Cited by 1,613
Membrane lipid homeostasis in bacteria
Zhang, Y.-M., & Rock, C. O. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1839 · Cited by 1,393 · cited 1×
“The acyl chains attached to the phospholipids determine the fluidity of the membrane, and proper membrane function requires that the acyl chain composition be controlled (63).”
BackgroundSelf-citationLipid biosynthesis as a target for antibacterial agents
Heath, R. J., White, S. W., & Rock, C. O. (2001) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00012-1 · Cited by 344 · cited 1×
“In practice, drug discovery efforts have primarily focused on four enzymes that are of regulatory significance (6, 20).”
BackgroundSelf-citationRole of commercial probiotic strains against human pathogen adhesion to intestinal mucus
Collado, M. C., Meriluoto, J., & Salminen, S. (2007) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2007.02212.x · Cited by 303 · cited 1×
“These species are usually considered beneficial for human health (50, 51), so the lack of inhibition of these microbes by fatty acid synthesis inhibitors may prove to be beneficial in maintaining the gut microbiome during antibiotic therapy.”
BackgroundSherman, P. M., Johnson-Henry, K. C., Yeung, H. P., Ngo, P. S. C., Goulet, J., & Tompkins, T. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.5183-5188.2005 · Cited by 246
Parsons, J. B., Broussard, T. C., Bose, J. L., Rosch, J. W., Jackson, P., Subramanian, C., & Rock, C. O. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408797111 · Cited by 182
Self-citation
Cited by
Bacterial Membranes: Structure, Domains, and Function
Strahl, H., & Errington, J. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-102215-095630 · Cited by 321
Tang, X., Li, J., Millán-Aguiñaga, N., Zhang, J. J., O’Neill, E. C., Ugalde, J. A., Jensen, P. R., Mantovani, S. M., & Moore, B. S. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00658 · Cited by 253
Host Fatty Acid Utilization by Staphylococcus aureus at the Infection Site
Frank, M. W., Yao, J., Batte, J. L., Gullett, J. M., Subramanian, C., Rosch, J. W., & Rock, C. O. (2020) · mBio · doi:10.1128/mbio.00920-20 · Cited by 57
Self-citationZhu, M., Frank, M. W., Radka, C. D., Jeanfavre, S., Xu, J., Tse, M. W., Pacheco, J. A., Kim, J. S., Pierce, K., Deik, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.07.029 · Cited by 61
Self-citationStructural assembly of the bacterial essential interactome
Gómez Borrego, J., & Torrent Burgas, M. (2024) · eLife · doi:10.7554/elife.94919 · Cited by 16
Metadata
- Authors
- Yao, J., & Rock, C. O.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 290
- Issue
- 10
- Pages
- 5940-5946
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2033322378
- Cited by
- 130
- References
- 6
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.